Marker Therapeutics, Inc.(MRKR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MRKR Marker Therapeutics, Inc.

交易中 07-22 13:38:21 EDT

5.00

-0.05

-0.89%

最高5.13	最低4.73	成交量4,581
今开5.13	昨收5.05	日振幅7.91%
总市值4,459万	流通市值3,380万	总股本891.91万
成交额2.27万	换手率0.07%	流通股本675.92万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"MRKR","market":"US","secType":"STK","nameCN":"Marker Therapeutics, Inc.","latestPrice":4.9999,"timestamp":1721669596651,"preClose":5.045,"halted":0,"volume":4581,"delay":0,"floatShares":6759214,"shares":8919095,"eps":-0.640628,"marketStatus":"交易中","marketStatusCode":2,"change":-0.0451,"latestTime":"07-22 13:38:21 EDT","open":5.1291,"high":5.1291,"low":4.73,"amount":22679.124633,"amplitude":0.079108,"askPrice":5.07,"askSize":18,"bidPrice":4.75,"bidSize":205,"shortable":0,"etf":0,"ttmEps":-0.640628,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1721678400000},"adr":0,"adjPreClose":5.045,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":5.045,"preClose":5.045,"latestTime":"17:09 EDT","volume":44,"amount":221.76,"timestamp":1721423381995},"volumeRatio":0.215769,"impliedVol":5.7071,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/MRKR","defaultTab":"news","newsList":[{"id":"2453999737","title":"Marker Therapeutics, Inc.盘中异动 股价大跌6.24%报4.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453999737","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453999737?lang=zh_cn&edition=full","pubTime":"2024-07-22 22:41","pubTimestamp":1721659304,"startTime":"0","endTime":"0","summary":"北京时间2024年07月22日22时41分，Marker Therapeutics, Inc.股票出现异动，股价急速下跌6.24%。截至发稿，该股报4.73美元/股，成交量2488股，换手率0.03%，振幅4.74%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.48%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722224144aefacc0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722224144aefacc0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","MRKR"],"gpt_icon":0},{"id":"2451990208","title":"Marker Therapeutics, Inc.盘中异动 早盘大幅上涨7.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451990208","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451990208?lang=zh_cn&edition=full","pubTime":"2024-07-16 21:53","pubTimestamp":1721137982,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日21时53分，Marker Therapeutics, Inc.股票出现异动，股价大幅拉升7.36%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716215302af9299c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716215302af9299c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","MRKR","BK4139"],"gpt_icon":0},{"id":"2450534952","title":"Marker Therapeutics, Inc.盘中异动 大幅拉升7.57%报5.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450534952","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450534952?lang=zh_cn&edition=full","pubTime":"2024-07-12 22:35","pubTimestamp":1720794953,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日22时35分，Marker Therapeutics, Inc.股票出现异动，股价大幅上涨7.57%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.84%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712223553af921f44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712223553af921f44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRKR","LENZ","BK4139"],"gpt_icon":0},{"id":"2450818277","title":"Marker Therapeutics, Inc.盘中异动 早盘股价大跌5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450818277","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450818277?lang=zh_cn&edition=full","pubTime":"2024-07-10 21:33","pubTimestamp":1720618427,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日21时33分，Marker Therapeutics, Inc.股票出现波动，股价大幅下挫5.56%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710213347af919c48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710213347af919c48&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MRKR","LENZ"],"gpt_icon":0},{"id":"2444198697","title":"Marker Therapeutics, Inc.盘中异动 急速上涨6.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444198697","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444198697?lang=zh_cn&edition=full","pubTime":"2024-06-17 21:52","pubTimestamp":1718632375,"startTime":"0","endTime":"0","summary":"北京时间2024年06月17日21时52分，Marker Therapeutics, Inc.股票出现异动，股价大幅上涨6.87%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.54%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240617215256af8de392&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240617215256af8de392&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","MRKR","BK4139"],"gpt_icon":0},{"id":"2442552586","title":"Marker Therapeutics, Inc.盘中异动 股价大跌9.33%报3.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442552586","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442552586?lang=zh_cn&edition=full","pubTime":"2024-06-12 21:35","pubTimestamp":1718199312,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日21时35分，Marker Therapeutics, Inc.股票出现异动，股价大幅跳水9.33%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061221351295a8e98e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061221351295a8e98e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","MRKR","BK4139"],"gpt_icon":0},{"id":"2440237955","title":"Marker Therapeutics, Inc.盘中异动 临近午盘大幅下跌6.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440237955","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440237955?lang=zh_cn&edition=full","pubTime":"2024-06-04 23:46","pubTimestamp":1717515994,"startTime":"0","endTime":"0","summary":"北京时间2024年06月04日23时46分，Marker Therapeutics, Inc.股票出现异动，股价快速下跌6.20%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604234635941ec4d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604234635941ec4d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","MRKR"],"gpt_icon":0},{"id":"2439992846","title":"Marker Therapeutics, Inc.盘中异动 股价大跌5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439992846","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439992846?lang=zh_cn&edition=full","pubTime":"2024-05-31 21:32","pubTimestamp":1717162325,"startTime":"0","endTime":"0","summary":"北京时间2024年05月31日21时32分，Marker Therapeutics, Inc.股票出现异动，股价急速下挫5.24%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.55%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531213205957fd5dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531213205957fd5dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRKR","BK4139","LENZ"],"gpt_icon":0},{"id":"2439005905","title":"Marker Therapeutics, Inc.盘中异动 快速上涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439005905","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439005905?lang=zh_cn&edition=full","pubTime":"2024-05-30 03:35","pubTimestamp":1717011326,"startTime":"0","endTime":"0","summary":"北京时间2024年05月30日03时35分，Marker Therapeutics, Inc.股票出现异动，股价急速拉升5.09%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.83%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530033526941eaf1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530033526941eaf1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","MRKR","BK4139"],"gpt_icon":0},{"id":"2439058929","title":"Marker Therapeutics, Inc.盘中异动 大幅下跌6.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439058929","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439058929?lang=zh_cn&edition=full","pubTime":"2024-05-29 02:25","pubTimestamp":1716920731,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日02时25分，Marker Therapeutics, Inc.股票出现波动，股价急速跳水6.28%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.92%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529022532968104ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529022532968104ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","MRKR"],"gpt_icon":0},{"id":"2437295850","title":"Marker Therapeutics, Inc.盘中异动 早盘股价大跌9.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2437295850","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437295850?lang=zh_cn&edition=full","pubTime":"2024-05-22 21:30","pubTimestamp":1716384623,"startTime":"0","endTime":"0","summary":"北京时间2024年05月22日21时30分，Marker Therapeutics, Inc.股票出现波动，股价急速下跌9.98%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522213023af89adb1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522213023af89adb1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRKR","LENZ","BK4139"],"gpt_icon":0},{"id":"2434041010","title":"Marker Therapeutics, Inc.盘中异动 股价大跌6.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434041010","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434041010?lang=zh_cn&edition=full","pubTime":"2024-05-10 00:52","pubTimestamp":1715273558,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日00时52分，Marker Therapeutics, Inc.股票出现波动，股价大幅下挫6.32%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.78%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510005239861ec274&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510005239861ec274&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","MRKR","BK4139"],"gpt_icon":0},{"id":"2433772427","title":"Marker Therapeutics, Inc.盘中异动 早盘股价大涨5.70%报4.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433772427","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433772427?lang=zh_cn&edition=full","pubTime":"2024-05-08 22:00","pubTimestamp":1715176856,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日22时00分，Marker Therapeutics, Inc.股票出现波动，股价急速拉升5.70%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050822005687e86742&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050822005687e86742&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MRKR","LENZ"],"gpt_icon":0},{"id":"2429902571","title":"Marker Therapeutics, Inc.盘中异动 股价大涨6.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429902571","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429902571?lang=zh_cn&edition=full","pubTime":"2024-04-23 21:32","pubTimestamp":1713879140,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日21时32分，Marker Therapeutics, Inc.股票出现波动，股价大幅上涨6.92%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.78%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042321322087a65b2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042321322087a65b2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","MRKR","BK4139"],"gpt_icon":0},{"id":"2428345397","title":"Marker Therapeutics, Inc.盘中异动 早盘快速拉升7.50%报4.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428345397","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2428345397?lang=zh_cn&edition=full","pubTime":"2024-04-17 21:31","pubTimestamp":1713360715,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日21时31分，Marker Therapeutics, Inc.股票出现波动，股价急速拉升7.50%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.67%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417213155878a1389&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417213155878a1389&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRKR","BK4139","LENZ"],"gpt_icon":0},{"id":"2427885135","title":"Marker Therapeutics, Inc.盘中异动 股价大涨5.54%报4.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427885135","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2427885135?lang=zh_cn&edition=full","pubTime":"2024-04-16 00:15","pubTimestamp":1713197703,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日00时15分，Marker Therapeutics, Inc.股票出现异动，股价快速拉升5.54%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.55%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240416001504861e5dc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240416001504861e5dc1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRKR","BK4139","LENZ"],"gpt_icon":0},{"id":"2427732763","title":"Marker Therapeutics, Inc.盘中异动 大幅跳水5.87%报4.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427732763","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2427732763?lang=zh_cn&edition=full","pubTime":"2024-04-13 00:02","pubTimestamp":1712937759,"startTime":"0","endTime":"0","summary":"北京时间2024年04月13日00时02分，Marker Therapeutics, Inc.股票出现异动，股价大幅下跌5.87%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.91%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240413000239861e5592&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240413000239861e5592&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MRKR","LENZ"],"gpt_icon":0},{"id":"2426666832","title":"Marker Therapeutics, Inc.盘中异动 早盘股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426666832","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426666832?lang=zh_cn&edition=full","pubTime":"2024-04-11 22:24","pubTimestamp":1712845470,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日22时24分，Marker Therapeutics, Inc.股票出现波动，股价大幅下跌5.15%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.11%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041122243187e7fa6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041122243187e7fa6b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","MRKR"],"gpt_icon":0},{"id":"2424893822","title":"Marker Therapeutics, Inc.盘中异动 快速上涨5.27%报4.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424893822","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2424893822?lang=zh_cn&edition=full","pubTime":"2024-04-04 00:49","pubTimestamp":1712162967,"startTime":"0","endTime":"0","summary":"北京时间2024年04月04日00时49分，Marker Therapeutics, Inc.股票出现波动，股价急速拉升5.27%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240404004927861e35b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240404004927861e35b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","MRKR","BK4139"],"gpt_icon":0},{"id":"2422992469","title":"Marker Therapeutics, Inc.盘中异动 股价大涨6.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422992469","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2422992469?lang=zh_cn&edition=full","pubTime":"2024-03-27 21:30","pubTimestamp":1711546224,"startTime":"0","endTime":"0","summary":"北京时间2024年03月27日21时30分，Marker Therapeutics, Inc.股票出现异动，股价急速上涨6.02%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032721302587e7c491&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032721302587e7c491&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MRKR","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.markertherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0354},{"period":"1month","weight":0.092},{"period":"3month","weight":0.2186},{"period":"6month","weight":0.1678},{"period":"1year","weight":-0.1592},{"period":"ytd","weight":-0.0827}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Marker Therapeutics, Inc.是一家临床阶段的免疫肿瘤学公司，专门开发下一代T细胞免疫疗法，用于治疗血液系统恶性肿瘤和实体肿瘤适应症。 Marker的细胞治疗技术基于非工程化的肿瘤特异性T细胞的选择性扩增，其识别肿瘤相关抗原（即肿瘤靶标）并杀死表达这些靶标的肿瘤细胞。一旦输入患者，这组T细胞攻击多个肿瘤靶标并起到激活患者免疫系统的作用，以产生广谱抗肿瘤活性。由于Marker不对其T细胞进行基因工程改造，因此与目前基于CAR-T和TCR的工程方法相比，其产品（i）的成本更低，更容易制造，（ii）毒性明显降低，（ iii）与有意义的临床益处相关。因此，与当前基因修饰的CAR-T和基于TCR的疗法相比，Marker认为其T细胞疗法组合具有引人注目的治疗产品特征。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":-0.027161},{"month":2,"riseRate":0.375,"avgChangeRate":-0.06492},{"month":3,"riseRate":0.5,"avgChangeRate":-0.065853},{"month":4,"riseRate":0.375,"avgChangeRate":0.001238},{"month":5,"riseRate":0.5,"avgChangeRate":0.232573},{"month":6,"riseRate":0.625,"avgChangeRate":0.292775},{"month":7,"riseRate":0.125,"avgChangeRate":-0.074002},{"month":8,"riseRate":0.428571,"avgChangeRate":0.039814},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.05017},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.105759},{"month":11,"riseRate":0.285714,"avgChangeRate":-0.078303},{"month":12,"riseRate":0.25,"avgChangeRate":0.056297}],"exchange":"NASDAQ","name":"Marker Therapeutics, Inc.","nameEN":"Marker Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Marker Therapeutics, Inc.(MRKR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Marker Therapeutics, Inc.(MRKR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Marker Therapeutics, Inc.,MRKR,Marker Therapeutics, Inc.股票,Marker Therapeutics, Inc.股票老虎,Marker Therapeutics, Inc.股票老虎国际,Marker Therapeutics, Inc.行情,Marker Therapeutics, Inc.股票行情,Marker Therapeutics, Inc.股价,Marker Therapeutics, Inc.股市,Marker Therapeutics, Inc.股票价格,Marker Therapeutics, Inc.股票交易,Marker Therapeutics, Inc.股票购买,Marker Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Marker Therapeutics, Inc.(MRKR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Marker Therapeutics, Inc.(MRKR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}